The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Maintenance treatment with toripalimab and anlotinib after anthracycline-based chemotherapy in patients with advanced soft tissue sarcoma (TORAN): A single-arm, phase 2 trial.
 
Yaotiao Deng
Speakers' Bureau - Chia Tai Tianqing Pharmaceutical Group; Eisai Europe; MSD; Novartis; Roche; Shanghai Junshi BioSciences; Shenzhen Chipscreen Biosciences
 
Jie Liu
Speakers' Bureau - MSD, Roche, Novartis, Eisai Europe Ltd, Shanghai Junshi Biosciences Co., Ltd, and Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
 
Mei Li
Speakers' Bureau - MSD, Roche, Novartis, Eisai Europe Ltd, Shanghai Junshi Biosciences Co., Ltd, and Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
 
Yu Jiang
Speakers' Bureau - Eisai Europe; MSD; Novartis; Roche; Shanghai Junshi BioSciences